|
⚲
|
| Keyboard |
| Gitelman Igor
✚
|
|
|---|---|
| CIK # | 0001698874 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001698874] | |
| 4 | [0001698874] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Gitelman Igor | |
| Ayala Pharmaceuticals Inc | |
| Cancer Genetics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2017-05-25 | Buy | 937 | $3.95 | 3,701 |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2017-05-23 | Option exercise | 937 | $2.50 | 2,342 |
|
Cancer Genetics Inc CGIX
Common Stock, par value $0.0001 per share
|
2017-05-23 | Sell | 937 | $4.02 | 3,767 |
|
Cancer Genetics Inc CGIX
Stock Option (right to buy) · derivative
|
2017-05-23 | Option exercise | 937 | $0.00 | |
|
Cancer Genetics Inc CGIX
Stock Option (right to buy) · derivative
|
2017-02-22 | Grant | 15,000 | $0.00 |